Investigations Differentiating Intravascular from Extravascular Hemolysis

Pathophysiologic Basis

Comparison Table

Key Differentiating Markers in Detail

1. Plasma Haptoglobin

• The most sensitive general hemolysis marker.
• Falls more steeply in intravascular hemolysis because free Hb floods the plasma and saturates haptoglobin (an α₂-globulin), forming Hb-haptoglobin complexes that are rapidly cleared by mononuclear phagocytes.
• In extravascular hemolysis, only small amounts of Hb escape from macrophages, so haptoglobin may be only mildly reduced.
• Caveat: haptoglobin is an acute-phase reactant — can be falsely normal in inflammation even with hemolysis. — Goldman-Cecil Medicine, p. 1674; Robbins Pathologic Basis of Disease, p. 596

2. Hemoglobinemia & Hemoglobinuria

• Specific for intravascular hemolysis.
• Free Hb in plasma imparts yellow → orange → pink color depending on level (>10 mg/dL = yellow; >25 mg/dL = pink).
• Once plasma Hb exceeds the renal tubular reabsorptive threshold, it spills into urine → hemoglobinuria (red-brown urine, dipstick positive for blood, no RBCs on microscopy).
• In extravascular hemolysis: no hemoglobinemia, no hemoglobinuria. — Henry's Clinical Diagnosis, p. 716

3. Hemosiderinuria

• Indicates chronic or recurrent intravascular hemolysis (e.g., PNH, mechanical heart valves).
• Mechanism: Hb filtered at the glomerulus is reabsorbed by proximal tubular cells → iron stored as hemosiderin → when tubular cells shed into urine, hemosiderin granules appear.
• Detected by Prussian blue stain of urine sediment (positive 3–4 days after an acute episode, persists for weeks).
• Absent in extravascular hemolysis. — Henry's Clinical Diagnosis, p. 716

4. Hemopexin & Methemalbumin

• When haptoglobin is exhausted, free Hb oxidises to methemoglobin → hemin groups are released and bound by hemopexin (a β-globulin) → cleared by liver.
• When hemopexin is also depleted, hemin binds to albumin → methemalbumin (detected by Schumm's test — spectroscopic).
• Both are specific markers of severe or sustained intravascular hemolysis. — Henry's Clinical Diagnosis, p. 716

5. LDH (Lactate Dehydrogenase)

• Released from lysed RBCs in both types, but more markedly elevated in intravascular hemolysis.
• LD₁ > LD₂ (reversal of normal isoenzyme pattern) — seen in hemolytic anemias.
• Upper normal ~207 IU/L; in hemolytic anemia may reach ~800 IU/L; in megaloblastic anemia (ineffective erythropoiesis), may reach several thousand. — Henry's Clinical Diagnosis, p. 716

6. Indirect (Unconjugated) Bilirubin & Urobilinogen

• Elevated in both types, but tend to predominate in extravascular hemolysis where haemoglobin is degraded intracellularly by macrophages.
• Bilirubin is unconjugated (bound to albumin) → does not appear in urine → no bilirubinuria (but urobilinogen is increased).
• Urine urobilinogen: normal 0.5–4 mg/24h; fecal urobilinogen: normal 40–280 mg/24h — both rise in hemolysis. — Henry's Clinical Diagnosis, p. 716

7. Peripheral Blood Smear Morphology

• Schistocytes (fragmented RBCs) → intravascular mechanical destruction (e.g., microangiopathic hemolytic anemia, prosthetic valves)
• Microspherocytes → partial membrane loss during extravascular phagocytosis (e.g., warm AIHA, hereditary spherocytosis)
• Note: Polychromasia and reticulocytosis are present in both. — Quick Compendium of Clinical Pathology, p. 8744

8. Splenomegaly

• Characteristic of extravascular hemolysis due to macrophage hyperplasia in the splenic cords.
• Absent in pure intravascular hemolysis. — Robbins Pathologic Basis of Disease, p. 596

Diagnostic Cascade Summary

General hemolysis markers (both types):
  ↑ LDH, ↓ haptoglobin, ↑ indirect bilirubin,
  ↑ reticulocytes, ↑ urobilinogen, polychromasia

      ↓
      
Intravascular-specific:          Extravascular-specific:
• Hemoglobinemia                  • Splenomegaly
• Hemoglobinuria                  • Microspherocytes
• Hemosiderinuria                 • ↑↑ indirect bilirubin
• ↓↓ haptoglobin                  • ↑↑ urobilinogen/stercobilinogen
• Methemalbumin (Schumm +)        • Normal plasma Hb
• ↓ hemopexin
• Schistocytes on smear

Causes of Intravascular vs. Extravascular Hemolysis

Intravascular Hemolysis

1. Mechanical / Physical Destruction

• Microangiopathic hemolytic anemia (MAHA) — fibrin strands or platelet thrombi shear RBCs:
  • Thrombotic thrombocytopenic purpura (TTP)
  • Hemolytic uremic syndrome (HUS — typical and atypical)
  • Disseminated intravascular coagulation (DIC)
  • HELLP syndrome
  • Malignant hypertension
  • Giant hemangioma / Kasabach-Merritt syndrome
• Prosthetic/dysfunctional heart valves (turbulent flow)
• March hemoglobinuria (foot-strike hemolysis — marathon runners, bongo drumming)
• Thermal injury (burns)

2. Complement Fixation on the RBC Surface

• ABO incompatible transfusion — IgM antibodies activate full complement cascade → MAC formation
• Paroxysmal nocturnal hemoglobinuria (PNH) — GPI-anchor deficiency → unregulated complement lysis (classic cause of chronic intravascular hemolysis)
• Paroxysmal cold hemoglobinuria (PCH) — Donath-Landsteiner IgG antibody fixes complement at cold temperatures, lysis occurs on rewarming

3. Infections

• Falciparum malaria ("blackwater fever") — direct RBC membrane rupture by merozoites + oxidant injury
• Babesiosis — intraerythrocytic parasite causing lysis
• Clostridial sepsis (C. perfringens) — phospholipases/lecithinases digest the RBC membrane

4. Toxic / Chemical

• Snake envenomation — phospholipases lyse membranes
• Spider bite (brown recluse — Loxosceles) — sphingomyelinase D
• Arsine gas (AsH₃) — severe oxidative Coombs-negative intravascular hemolysis + renal failure
• Copper (Wilson's disease crisis, ingestion)
• Lead poisoning (also inhibits erythropoiesis)
• Drug oxidants in G6PD deficiency — extreme oxidant load causes both intravascular and extravascular hemolysis

Extravascular Hemolysis

1. Membrane / Structural Defects (Congenital)

• Hereditary spherocytosis — spectrin/ankyrin/band 3 mutations → spherocytes trapped in splenic cords
• Hereditary elliptocytosis / pyropoikilocytosis
• Hereditary stomatocytosis

2. Enzyme Deficiencies

• G6PD deficiency — oxidant triggers (drugs: primaquine, dapsone; fava beans; infections) → Heinz body formation → extravascular removal (also some intravascular component with severe oxidant load)
• Pyruvate kinase (PK) deficiency — rigid, deformability-impaired RBCs

3. Hemoglobinopathies

• Sickle cell disease — deoxygenated HbS polymers → rigid sickled cells → splenic/hepatic trapping; also vaso-occlusion
• Thalassemia syndromes — excess unpaired globin chains precipitate → damaged membrane → phagocytosis; also ineffective erythropoiesis (intramedullary hemolysis)
• Other unstable hemoglobins

4. Immune-Mediated (Predominantly Extravascular)

• Warm autoimmune hemolytic anemia (WAIHA) — IgG-coated RBCs opsonised → splenic macrophage phagocytosis via FcγR (most common form of AIHA; occasional intravascular component at onset)
• Cold agglutinin disease (CAD) — IgM fixes C3b → primarily hepatic (Kupffer cell) extravascular clearance; massive complement activation can cause intravascular component
• Drug-induced immune hemolytic anemia — hapten, immune complex, or autoantibody mechanisms → extravascular (most) or intravascular
• Alloimmune — delayed hemolytic transfusion reactions (non-ABO; e.g., anti-Kidd/Jk^a)
• Hemolytic disease of the fetus and newborn (HDFN) — anti-D, anti-c, anti-Kell

5. Hypersplenism

• Congestive splenomegaly (portal hypertension, storage diseases, infiltrative disorders) — non-selective sequestration of all blood elements

6. Acquired Membrane Defects

• Spur cell anemia (acanthocytosis) — severe liver disease → abnormal membrane lipid composition → splenic trapping
• PNH — also causes extravascular component via C3b opsonisation (in addition to intravascular lysis)

Summary Mnemonic

Hemolytic Disease of the Fetus and Newborn (HDFN)

Definition

Pathophysiology

1. Mother lacks a specific RBC antigen
2. Fetal RBCs bearing that antigen enter maternal circulation (fetomaternal hemorrhage — FMH)
3. Mother mounts an IgG alloimmune response
4. IgG crosses the placenta → binds fetal RBC antigen
5. IgG-coated fetal RBCs are destroyed by macrophages in the fetal spleen/liver → extravascular hemolysis
6. Results in fetal anaemia → compensatory extramedullary erythropoiesis → erythroblastemia → if severe → hydrops fetalis
7. After birth, neonatal jaundice develops (bilirubin cannot be cleared by the immature liver; unconjugated bilirubin crosses the blood-brain barrier → kernicterus)

Causes by Antibody System

1. Rh System — Most Clinically Significant

Anti-D: Without RhIg, risk of sensitization in Rh− mother carrying Rh+ fetus ~15%. With antenatal + postnatal RhIg: 0.1%.

• Normal pregnancy, delivery
• Spontaneous/elective abortion
• Chorionic villus sampling, amniocentesis, cordocentesis
• Placental abruption, ectopic pregnancy, trauma

2. Kell System

3. ABO Incompatibility — Most Common Overall

4. Other Blood Group Antibodies (selected)

More than 60 different antibodies have been associated with HDFN. — Creasy & Resnik's Maternal-Fetal Medicine

Clinical Spectrum

Investigations & Monitoring

Antenatal

Postnatal

Tests for Fetomaternal Hemorrhage (for RhIG dosing)

Dose (vials) = (Maternal blood volume in mL × proportion fetal cells) ÷ 30 Each 300 μg vial protects against 30 mL whole blood (15 mL packed RBCs) Always round up and add 1 vial; max 5 vials IM at one time

Management

Prevention (Rh HDFN)

• Rh− women without antibodies: RhIg 300 μg at 28 weeks + at delivery; also after any sensitising event (miscarriage, amniocentesis, trauma)
• Weak D type 1, 2, or 3: not at risk for alloimmunisation → RhIg not indicated (genotyping required to confirm)
• Already immunised (anti-D present): RhIg has no benefit

Fetal Treatment

• Intrauterine transfusion (IUT) — via cordocentesis; indicated when MCA-PSV >1.5 MoM (fetal Hb <70 g/L); generally performed up to 34 weeks' gestation
• Delivery at 37–38 weeks unless earlier delivery clinically indicated

Neonatal Treatment

• Phototherapy — converts unconjugated bilirubin to water-soluble isomers for excretion
• Exchange transfusion — removes IgG-coated RBCs, reduces bilirubin, corrects anaemia; antigen-negative, irradiated, CMV-safe blood used
• IVIG — reduces rate of haemolysis in severe cases

Management Flowchart

Mechanistic Basis of Intravascular vs. Extravascular Destruction

The Central Decision: Does Complement Go to Completion?

Antibody binds RBC antigen
         ↓
Classical pathway activated: C1 → C4 → C2 → C3
         ↓
C3b deposited on RBC membrane
         ↓
    Two outcomes:
    
ARRESTED HERE              PROCEEDS FURTHER
(Extravascular)            (Intravascular)
    ↓                           ↓
C3b → iC3b → C3dg          C5 → C5b → C6,7,8,9
(by Factor I, Factor H,    → MAC (C5b-6789)
CR1, DAF)                  → osmotic pore in
    ↓                         membrane
Opsonised RBC              → cell swells and bursts
phagocytosed by RES        → intravascular lysis

Why Complement Usually Stops at C3 (Protecting Against Intravascular Lysis)

This is the precise defect in PNH: the GPI anchor biosynthesis gene (PIG-A) is mutated → CD55 and CD59 are absent → complement runs to completion → intravascular lysis. — Henry's Clinical Diagnosis and Management by Laboratory Methods

The Role of Immunoglobulin Class

IgM → Intravascular Hemolysis

• IgM is a pentamer: 10 antigen-binding sites
• A single IgM molecule can simultaneously bind two Fc sites and activate C1q → classical pathway fires vigorously
• IgM fixes complement very efficiently → large amounts of C3b generated rapidly → overwhelms regulatory proteins → cascade proceeds to MAC
• Prototype: ABO incompatibility (anti-A, anti-B are IgM); cold agglutinin disease (IgM)
• IgM itself is too large to bind Fc receptors on macrophages → cannot directly cause extravascular phagocytosis

IgG → Predominantly Extravascular Hemolysis

• IgG is a monomer: two antigen-binding sites
• Requires multiple IgG molecules in close proximity to cooperatively activate C1q → complement activation is weak and slow
• Complement regulatory proteins (DAF, Factor I) stop the cascade at C3b → no MAC formed
• C3b-coated RBCs are opsonised and cleared by macrophages in the liver (via CR1/CR3 receptors for C3b/iC3b)
• Simultaneously, Fcγ receptors on splenic macrophages bind the IgG Fc tail directly → phagocytosis in the spleen
• Prototype: warm AIHA (IgG1, IgG3); HDFN due to anti-D

Exception: IgG anti-Kidd antibodies are highly complement-fixing and can cause intravascular hemolysis despite being IgG. This is because anti-Kidd fixes complement unusually efficiently. — Henry's Clinical Diagnosis and Management by Laboratory Methods

Mechanism of Extravascular Destruction in Detail

• Splenic macrophages: bind IgG via FcγRI (CD64) and FcγRIII (CD16)
• Hepatic Kupffer cells: bind C3b via CR1 and iC3b via CR3 (CD11b/CD18)

RBCs coated with both IgG and C3b are cleared faster via the liver; those coated with IgG alone are destroyed more slowly in the spleen. — Henry's Clinical Diagnosis and Management by Laboratory Methods

Non-Immune Mechanisms

Summary Diagram

One-Line Summary

Intravascular hemolysis occurs when complement activation is rapid and overwhelming (typically IgM, or complement-fixing IgG, or direct toxic/mechanical injury), bypassing regulatory proteins and forming the MAC. Extravascular hemolysis occurs when complement activation stalls at C3b (or antibody is IgG without complement), leaving RBCs opsonised for phagocytosis by splenic and hepatic macrophages via Fcγ and complement receptors.